Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 804 results for "herceptin"

Potentially Powerful New Way to Treat HER2-Positive Breast Cancer
Med India

Biocon's CANMAb, a biosimilar version of Roche's HER2-positive...

Biocon's CANMAb a biosimilar version of Roche's HER2-positive breast cancer treatment Herceptin (trastuzumab) is to launch on the Indian market in the first week of February. Kiran Mazumdar-Shaw managing director of Biocon has been quick to ... TransWorldNews, 2 weeks ago

57 images for herceptin

Chemist+Druggist, 1 week ago
UK Nigeria Online, 1 month ago
Pharma Letter, 4 weeks ago
Timmins Daily Press, 1 month ago
The Sentinel, 1 month ago
The Sentinel, 1 month ago
The Sentinel, 1 month ago
The Sentinel, 1 month ago
OncLive, 1 month ago
Daily Finance, 1 month ago

Medicamentos falsificados - Alimta, Avastin, Avonex, Copaxone, Exjade, Faslodex, Herceptin, Kivexa, Mabthera, Neulasta, Remicade, Velcade e Xeloda

You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: Medicamentos falsificados - Alimta, Avastin, Avonex, Copaxone, Exjade, Faslodex, Herceptin, Kivexa, ...
 FirstWord Pharma1 week ago
Med India

Single Agent Remains the Gold Standard, ALTTO Test of Dual HER2 Blockade Reveals

Lapatinib (Tykerb) did not add benefit to the standard trastuzumab (Herceptin) adjuvant therapy in the largest clinical trial testing the effectiveness of one versus two drugs to treat HER2-positive breast cancer, researchers report at the 50th annual meeting ...
 Med India2 months ago Puma Biotechnology Announces Positive Top Line Results from Phase III PB272 Trial in Adjuvant Breast Cancer ExteNET Trial  Pharmacy Choice1 week ago Puma Biotechnology reports positive data from Phase III breast cancer trial  Individual.com1 week ago Patent Application Titled "Triterpene Glycoside and Triterpene Compositions and Methods of Using Same" Published Online  HispanicBusiness.com2 weeks ago
[x]  

Forum Post: heart rate

Hi I know we are not medically trained but does anybody know what your testing heart rate should be I am on herceptin iv and rads started on Monday and last night and today my heart rate is 108 bmp, I don't know if this is normal or not but I ...
 Macmillan Cancer Support1 week ago Forum Post: RE: heart rate  Macmillan Cancer Support1 week ago

Forum Post: acupuncture

Has anyone had acupuncture whilst having chemo and herceptin? My friend does acupuncture, she has her own practice and she has said she will do mine free of charge and it really helps. I don't know much about it, my friend is in spain not back in ...
 Macmillan Cancer Support2 weeks ago

Forum Post: Pericarditis anyone?

Anyone had this whilst on Herceptin and rads? Just when I thought the end of side effects was in sight! If anyone has been unfortunate enough to have this, how was it dealt with and how long did it take before it
 Macmillan Cancer Support4 weeks ago Forum Post: RE: New Person!!!  Macmillan Cancer Support2 weeks ago Forum Post: New Person!!!  Macmillan Cancer Support2 weeks ago Forum Post: last chemo!!!!!  Macmillan Cancer Support4 weeks ago

Forum Post: All my treatment nearly finished, weird feeling.

Approaching the end of treatment. Last two herceptins are next month. Feeling a bit weird, but at the same time relief I guess. I have been super annoyed the whole way through having this extra time added on to treatment, I am aware that I am lucky ...
 Macmillan Cancer Support3 weeks ago

GBR 1302 could be an out-licencing opportunity: Glenmark

Michael Buschle Chief Scientific Officer Glenmark Pharmaceuticals According to Buschle, GBR 1302 molecule is a genetically engineered molecule and will be used for the study of breast cancer. The company may look to out-license the new molecule ...
 Moneycontrol.com16 hours ago

Source BioScience PLC Half Yearly Report

Source Bio. (SBS) Quote : 11.625 0.375 (3.33%) @ 08:00 HOME » LSE » LSE » Source Bioscience share price TIDMSBS RNS Number : 5669P Source BioScience PLC 20 August 2014 20 August 2014 Source BioScience plc ('Source BioScience' or ...
 ADVFN UK17 hours ago Source Bioscience : Half Yearly Report  4 Traders19 hours ago Half Yearly Report  TrustNet19 hours ago
Business Standard India

Pharma shares on a roll; BSE Healthcare index up 3%

Cipla, Sun Pharma, Lupin, Cadila Healthcare, Aurobindo and Glenmark are up 2-4%, quoting at their lifetime highs. Deepak Korgaonkar | Mumbai August 20, 2014 Last Updated at 13:27 IST Shares of pharmaceutical companies are on a roll with most of the ...
 Business Standard India18 hours ago Glenmark Pharma at new high, up 4% on foray into oncology  Moneycontrol.com20 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less